Market Background 1.2 Executive Summary 1.3 Research Methodology 2
BMC Cardiovasc Disord, 2014, 14, 88
Merck is projecting their 2023 worldwide sales to amount to between $57.7 billion and $58.9 billion
The oral formulation appears to be bringing new patients into treatment rather than simply shifting share among existing users
Used to screen for diabetes or prediabetes Lipid panel : Checks cholesterol levels, which are key for heart health Comprehensive metabolic panel (CMP): Evaluates kidney and liver function to ensure medication safety High-sensitivity C-reactive protein (CRP): Detects inflammation, a marker tied to chronic disease risk [1] Fasting insulin: Assesses insulin resistance, often linked to weight gain and metabolic issues [2] Thyroid-stimulating hormone (TSH): Screens for thyroid imbalances that can affect weight and energy These labs help your clinician choose the safest and most effective GLP-1 medication for you
Glucagon-like peptide-1 (GLP-1) receptor agonists are established treatments for type 2 diabetes mellitus and obesity in the UK, typically administered via subcutaneous injection